NIH Funding Acknowledgement

Use of any ICTS Core or service, including participation in a CRTC Training Program, requires the NIH Funding Acknowledgement for all publications and projects.

Each scholar is required to cite the ICTS UL1 TR000448 grant number and the appropriate sub-award dependent on the scholar’s program. Scholars should select their appropriate program from the menu on the right-hand side of this page for specific information regarding their grant.

NIH-funded investigators are required to submit (or have submitted for them) their final, peer-reviewed manuscript to PubMed Central (PMC) upon acceptance of publication to be made publicly available within 12 months of publication. This policy applies to NIH-funded manuscripts accepted for publication on or after April 7, 2008. Note: PMCID is not the same as PMID.

All CRTC scholars and alumni are required to obtain a PubMed Central ID (PMCID) for works supported by NIH funding. The NIH will now withhold funding to enforce the PMCID policy. More information about complying with the PMCID policy can be found here.

CRTC Tracking

For publication tracking purposes, please forward the PDF file, copy of the approved publication, the PMCID, or NIHMS ID to Angela Wilson. Questions can be directed to Angela at (314) 454-8936.

Information on the National Center for Advancing Translational Sciences (NCATS) is available at http://www.ncats.nih.gov. Information about the Clinical and Translational Science Awards may be found at http://www.ncats.nih.gov/research/cts/cts.html.

Publication Requirements

Applicable clinical trials must be registered with ClinicalTrials.gov.

Grant Citation by Program

• ASPIRE Grant Citation

  Students who participate in the CRTC's ASPIRE Program should cite the grant on all publications, presentations, and projects that began or were completed during the program.

  ASPIRE students should cite the following NIH Funding Acknowledgment:

  This publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

  Dr. Bradley Evanoff is the PI for the Clinical and Translational Science Award (CTSA) that supports all ICTS and CRTC activities.

  All CRTC scholars and alumni are required to obtain a PubMed Central ID (PMCID) for works supported by NIH funding. The NIH will now withhold funding to enforce the PMCID policy. See below for more information about complying with the PMCID policy.

• Doris Duke Grant Citation

  All publications (as well as posters and/or abstracts at scientific meetings) reporting work funded by the Doris Duke Fellowship should acknowledge that support using the following statement:

  This work was supported by a grant from the Doris Duke Charitable Foundation to Washington University to fund Doris Duke Clinical Research Fellow (Fellow's Name).

• KL2 Grant Citation

  Scholars who participate in the CRTC's KL2 Career Development Program should cite the grant on all publications, presentations, and projects that began or were completed during the program.

  KL2 Scholars should cite the following NIH Funding Acknowledgment:

  This publication was supported by the Washington University Institute of Clinical and Translational Sciences grants UL1 TR000448 and KL2 TR000450 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

  Dr. Bradley Evanoff is the PI for the Clinical and Translational Science Award (CTSA) that supports all ICTS and CRTC activities.

  All CRTC scholars and alumni are required to obtain a PubMed Central ID (PMCID) for works supported by NIH funding. The NIH will now withhold funding to enforce the PMCID policy. See below for more information about complying with the PMCID policy.

• MSCI Grant Citation

  Scholars who participate in the CRTC's MSCI Program and receive tuition support should cite the grant on all publications, presentations, and projects that began or were completed during the program.

  MSCI Scholars should cite the following NIH Funding Acknowledgment:

  This publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

  Dr. Bradley Evanoff is the PI for the Clinical and Translational Science Award (CTSA) that supports all ICTS and CRTC activities.

  All CRTC scholars and alumni are required to obtain a PubMed Central ID (PMCID) for works supported by NIH funding. The NIH will now withhold funding to enforce the PMCID policy. See below for more information about complying with the PMCID policy.

• Postdoctoral MTPCI Grant Citation

  Scholars who participate in the CRTC's MTPCI program should cite the grant on all publications, presentations, and projects that began or were completed during the program.

  MTPCI Scholars should cite the following NIH Funding Acknowledgment:

  This publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

  Dr. Bradley Evanoff is the PI for the Clinical and Translational Science Award (CTSA) that supports all ICTS and CRTC activities.

  All CRTC scholars and alumni are required to obtain a PubMed Central ID (PMCID) for works supported by NIH funding. The NIH will now withhold funding to enforce the PMCID policy. See below for more information about complying with the PMCID policy.

• TL1 Predoctoral Grant Citation

  Scholars who participate in the CRTC's TL1 Predoctoral Program (including Summer, Standard, and Intensive) should cite the grant on all publications, presentations, and projects that began or were completed during the program.

  TL1 Scholars should cite the following NIH Funding Acknowledgment:

  This publication was supported by the Washington University Institute of Clinical and Translational Sciences grants UL1 TR000448 and TL1 TR000449 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

  Dr. Bradley Evanoff is the PI for the Clinical and Translational Science Award (CTSA) that supports all ICTS and CRTC activities.

  All CRTC scholars and alumni are required to obtain a PubMed Central ID (PMCID) for works supported by NIH funding. The NIH will now withhold funding to enforce the PMCID policy. See below for more information about complying with the PMCID policy.

 

PubMed Central ID (PMCID)

NIH-funded investigators are required to submit (or have submitted for them) their final, peer-reviewed manuscript to PubMed Central (PMC) upon acceptance of publication to be made publicly available within 12 months of publication. This policy applies to NIH-funded manuscripts accepted for publication on or after April 7, 2008. Note: PMCID is not the same as PMID.

What is a PMCID?

A PMCID or PubMed Central ID is an identifier assigned to articles published in the US National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature.

Why do I need a PMCID?

Since you are/were funded by the NIH, you are legally required to obtain a PMCID. The NIH will now withhold funding to enforce its policy as referenced in this article published in Nature . Authors will not be allowed to list publications on NIH grant applications or progress reports if those publications are not in compliance with the policy.

Once an article is published, how long do I have to demonstrate compliance with the PMCID policy?

You are required to obtain a PMCID within three months of publication of your article.

How do I know if my article is in compliance?

Check with your publisher about their method of compliance. There are four methods to achieve compliance with this policy. The method is entirely dependent on your journal or publisher. When submitting your article, be sure to ask about their policies for complying with the NIH Open Access Policy. Ultimately, it is the responsibility of the authors to demonstrate compliance with the NIH Open Access Policy.

• Method A: Author publishes in a journal that submits all NIH-funded final published articles to PubMed Central (PMC); no fee.
• Method B: Author pays a publisher a fee to submit an individual final published article to PMC.
• Method C: Author self-submits the final peer-reviewed manuscript to the NIH Manuscript Submission system (NIHMS) in preparation for posting to PMC. Authors may also ask Becker Library to submit the article on their behalf. See the library's website for more information.
• Method D: Publisher submits the final peer-reviewed manuscript to NIHMS on behalf of the NIH-funded authors in preparation for posting to PMC; no fee.

I have a PMCID, now what?

Affix the PMCID number to the appropriate article in your Biosketch, CV, and Progress Report Materials. The PMCID number demonstrates compliance with the NIH's policy.

Specific questions about PMCIDs should be directed to This email address is being protected from spambots. You need JavaScript enabled to view it. in the Becker Library.